EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

NCT00574860 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

240

Enrollment

INDUSTRY

Sponsor class

Stopped Additional research

Conditions

Oral Mucositis
Head and Neck Cancer

Interventions

DRUG: EN3285
DRUG: Placebo
OTHER: Standard of care

Sponsor

Endo Pharmaceuticals